金斯瑞生物科技(01548.HK)獲3名董事增持約140萬股 對公司發展前景充滿信心
格隆匯9月24日丨金斯瑞生物科技(01548.HK)發佈公告,公司董事會獲公司執行董事及控股股東王燁女士告知,於2020年9月22日、9月23日及9月24日,王女士於市場上收購合共63.8萬股公司普通股,總代價約7,553,560港元(相當於平均價格每股股份約11.839港元)。
董事會亦獲公司非執行董事及控股股東王魯泉博士告知,於2020年9月22日,王博士的一名緊密聯繫人於市場上收購合共63.8萬股股份,總代價約7,614,720港元(相當於平均價格每股股份約11.935港元)。
董事會亦獲公司執行董事孟建革先生告知,於2020年9月22日、23日及24日,孟先生於市場上收購合共12萬股股份,總代價約1,416,200港元(相當於平均價格每股股份約11.802港元)。
王女士及王博士為與公司非執行董事及主席章方良博士一致行動的人士。緊隨王女士收購及王博士收購後,王女士及王博士各自被視為擁有9.45億股股份的權益,佔公司於本公告日期的全部已發行股本約49.15%。
緊隨孟先生收購後,孟先生擁有282.5萬股股份的權益,佔公司於本公告日期的全部已發行股本約0.15%。
公司相信,收購事項充分表明王女士、王博士及孟先生對集團的整體發展前景及增長潛力具有信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.